Additionally, HIPK3 expression serves as a valuable biomarker for survival and prognosis in non-small cell lung cancer (9), and low HIPK3 expression correlates with poor prognosis in renal cell carcinoma (7). This evidence concerns the gene HIPK3 and renal cell carcinoma.